Citius Chairman and CEO, Leonard Mazur, along with members of the management team and Dr. Issam Raad discussed the results of the Phase 3 Trial and the clinical need for Mino-Lok in patients with catheter-related bloodstream infections. A question and answer period followed management’s discussion.
The call was held on Monday, June 3, 2024 at 8:30 a.m. Eastern Time.
A webcast replay can be accessed here.